1 active not recruiting, 1 terminated, 1 withdrawn. 2 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Terminated 1, Withdrawn 1 |
| Phase 2 | 1 | Active not recruiting 1 |
Follow Rezafungin Acetate: new trials by email Literature Review of Rezafungin Acetate trials Research Report on Rezafungin Acetate
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Rezafungin for Treatment of Chronic Pulmonary Aspergillosis (CPA) in Adults With Limited Treatment Options Rezafungin Acetate - Chronic Pulmonary Aspergillosis | Phase 2 | Active not recruiting | Mundipharma Research Limited | 60 | 2025-06-30 | 2026-05-14 |
| Rezafungin Pharmacokinetics in Patients on ECMO Rezafungin - Sepsis | Phase 1 | Withdrawn | Hartford Hospital | 2024-07-01 | 2024-12-17 | |
| Rezafungin Paediatric PK Study in Paediatric Subjects From Birth to <18 Years of Age Rezafungin Acetate - Invasive Fungal Infections | Phase 1 | Terminated | Mundipharma Research Limited | 32 | 2023-09-13 | 2025-04-06 |
Invasive Fungal Infections (1) · Sepsis (1)
Mundipharma Research Limited (2) · Hartford Hospital (1)
Germany (2) · Spain (2) · United Kingdom (2) · Austria (1) · Belgium (1) · France (1) · Hungary (1) · Italy (1) · Netherlands (1) · South Korea (1)